SE500706C2 - Dikloranilinförening - Google Patents
DikloranilinföreningInfo
- Publication number
- SE500706C2 SE500706C2 SE9101687A SE9101687A SE500706C2 SE 500706 C2 SE500706 C2 SE 500706C2 SE 9101687 A SE9101687 A SE 9101687A SE 9101687 A SE9101687 A SE 9101687A SE 500706 C2 SE500706 C2 SE 500706C2
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- formula
- amino
- solution
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909012465A GB9012465D0 (en) | 1990-06-05 | 1990-06-05 | Chemical compounds |
GB919104645A GB9104645D0 (en) | 1991-03-05 | 1991-03-05 | Chemical compound |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9101687D0 SE9101687D0 (sv) | 1991-06-04 |
SE9101687L SE9101687L (sv) | 1991-12-06 |
SE500706C2 true SE500706C2 (sv) | 1994-08-15 |
Family
ID=26297165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9101687A SE500706C2 (sv) | 1990-06-05 | 1991-06-04 | Dikloranilinförening |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0460924A1 (de) |
JP (1) | JPH05117236A (de) |
KR (1) | KR920000717A (de) |
AP (1) | AP251A (de) |
AT (1) | AT399874B (de) |
AU (1) | AU635424B2 (de) |
BE (1) | BE1005612A5 (de) |
CA (1) | CA2043850A1 (de) |
CH (1) | CH682322A5 (de) |
DE (1) | DE4118293A1 (de) |
DK (1) | DK106991A (de) |
ES (1) | ES2036920B1 (de) |
FI (1) | FI912679A (de) |
FR (1) | FR2662691A1 (de) |
GB (1) | GB2244709B (de) |
GR (1) | GR1001309B (de) |
IE (1) | IE911898A1 (de) |
IL (1) | IL98363A0 (de) |
IT (1) | IT1245868B (de) |
LU (1) | LU87945A1 (de) |
MY (1) | MY106672A (de) |
NL (1) | NL9100960A (de) |
OA (1) | OA09501A (de) |
PT (1) | PT97858A (de) |
SE (1) | SE500706C2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9104650D0 (en) * | 1991-03-05 | 1991-04-17 | Glaxo Group Ltd | Medicaments |
ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
GB0014546D0 (en) | 2000-06-14 | 2000-08-09 | Glaxo Group Ltd | A novel process |
FR2960153B1 (fr) * | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1618005A1 (de) * | 1966-09-22 | 1971-09-09 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen |
EP0021636B1 (de) * | 1979-06-16 | 1982-12-01 | Beecham Group Plc | Sekundäre Amine, ihre Herstellung und Verwendung in pharmazeutischen Zusammensetzungen |
GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
GB8603475D0 (en) * | 1986-02-12 | 1986-03-19 | Glaxo Group Ltd | Chemical compounds |
ES8802416A1 (es) * | 1986-04-15 | 1988-06-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de derivados de dicloroanilina. |
-
1991
- 1991-06-04 CA CA002043850A patent/CA2043850A1/en not_active Abandoned
- 1991-06-04 GR GR910100242A patent/GR1001309B/el unknown
- 1991-06-04 JP JP3159631A patent/JPH05117236A/ja active Pending
- 1991-06-04 SE SE9101687A patent/SE500706C2/sv unknown
- 1991-06-04 ES ES9101342A patent/ES2036920B1/es not_active Expired - Fee Related
- 1991-06-04 IE IE189891A patent/IE911898A1/en unknown
- 1991-06-04 PT PT97858A patent/PT97858A/pt not_active Application Discontinuation
- 1991-06-04 DE DE4118293A patent/DE4118293A1/de not_active Withdrawn
- 1991-06-04 EP EP91305057A patent/EP0460924A1/de not_active Withdrawn
- 1991-06-04 AT AT0112891A patent/AT399874B/de not_active IP Right Cessation
- 1991-06-04 OA OA60012A patent/OA09501A/xx unknown
- 1991-06-04 CH CH1651/91A patent/CH682322A5/fr not_active IP Right Cessation
- 1991-06-04 AU AU78127/91A patent/AU635424B2/en not_active Ceased
- 1991-06-04 FI FI912679A patent/FI912679A/fi not_active Application Discontinuation
- 1991-06-04 NL NL9100960A patent/NL9100960A/nl not_active Application Discontinuation
- 1991-06-04 BE BE9100536A patent/BE1005612A5/fr not_active IP Right Cessation
- 1991-06-04 KR KR1019910009211A patent/KR920000717A/ko not_active Application Discontinuation
- 1991-06-04 FR FR9106741A patent/FR2662691A1/fr active Granted
- 1991-06-04 GB GB9111946A patent/GB2244709B/en not_active Expired - Fee Related
- 1991-06-04 MY MYPI91000987A patent/MY106672A/en unknown
- 1991-06-04 IL IL98363A patent/IL98363A0/xx unknown
- 1991-06-04 AP APAP/P/1991/000271A patent/AP251A/en active
- 1991-06-04 LU LU87945A patent/LU87945A1/fr unknown
- 1991-06-04 DK DK106991A patent/DK106991A/da not_active Application Discontinuation
- 1991-06-04 IT ITRM910387A patent/IT1245868B/it active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5789405A (en) | Oxaspiro(2,5)octane derivative | |
EP1720872B1 (de) | Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren | |
DE69615025T2 (de) | Benzamid-derivate und deren verwendung als vasopressin-antagonisten | |
EP2345629B1 (de) | Fluorenverbindung und ihre verwendung für medizinische zwecke | |
US5399577A (en) | Isoxazole derivatives and salts thereof | |
BR112021015853A2 (pt) | Compostos de tieno[3,2-b]piridin-7-amina para o tratamento de disautonomia familiar | |
US5318970A (en) | Isoxazole compounds, pharmaceutically acceptable salts thereof and medical uses thereof | |
FR2945531A1 (fr) | Derives de 7-aza-spiro°3,5!nonane-7-carboxylates, leur preparation et leur application en therapeutique | |
NO165192B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
EP0372484A2 (de) | Kondensierte Benzen-Derivate | |
US5478856A (en) | Styrene derivatives and salts thereof | |
US20190389836A1 (en) | Nrf2 activator | |
JPH03133946A (ja) | フェンエタノールアミン化合物 | |
EP0406112B1 (de) | 1-Benzhydrylazetidine, deren Herstellung und Verwendung als Zwischenprodukte zur Herstellung von Verbindungen mit antimikrobieller Wirkung | |
EP1439164B1 (de) | Neue phenylethanolaminverbindungen mit erregender wirkung an beta2-akzeptor und verfahren zu deren herstellung | |
EP0499995B1 (de) | Piperidinderivate | |
SE500706C2 (sv) | Dikloranilinförening | |
EP0737678A1 (de) | 4-Indolylpiperazinyl-Derivate | |
EP0487270A2 (de) | HIV-Proteaseinhibitoren mit Polyether-Substituenten | |
CN107556276B (zh) | C-三芳基葡萄糖苷类化合物及其制备方法和应用 | |
NO309475B1 (no) | Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel | |
EP0217135B1 (de) | Spiro[benzofuran-2(3H), 1'-cycloheptane], Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
EP0404748B1 (de) | Stereoisomere | |
US5654461A (en) | Sulfamate compound containing carbamoyl group | |
FR2741071A1 (fr) | Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique |